Sanofi Ventures co-led replacement therapy developer Glycomine's latest round, which included Novo, Asahi Kasei Pharma Ventures and Chiesi Ventures.

Eli Lilly, Johnson & Johnson and Pfizer helped drug developer TRexBio close its $59m series A round while Slack backed human resources software provider Oyster at a $475m valuation.

Matrix Partners China and Citic Private Equity Funds Management co-led the series B round, which will fund development of treatments for rare medical conditions.

Morgan Stanley, NTT Data, Sumitomo Mitsui Trust Bank, Ripple, Ripio and Mouro Capital helped the tokenisation technology provider take its total funding to over $74m.

Maersk Growth and Raed Ventures co-led a $42m round for shipping platform developer Trella while GV exited deep learning software provider Determined AI.

The Cornell cardiovascular data technology spinout has launched with $54m in funding, $43m coming from an American College of Cardiology-backed series B round.

Crypto financial services firm Amber has followed a Coinbase and Blockchain.com-backed series A round by adding $100m in series B funding.

The cardiovascular data technology developer has launched with $54m in funding, $43m coming from a Cigna Ventures-backed series B round.

Tencent, Credit Saison and JG Summit have all contributed to a $16m round for GrowSari while Greenvolt is set to acquire up to 29% of solar system installer Perfecta Energía.

Nutreco and Olympic Investments co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.